Tuesday, November 6, 2018

UPDATE 1-Sanofi and Regeneron's Dupixent gets more positive feedback from U.S. FDA

The U.S. Food & Drug Administration (FDA) regulator has given more positive feedback on the Dupixent eczema treatment being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday.
https://ift.tt/2APM855 support@endlesssupplies.biz (Endless Supplies .Biz) November 06, 2018 at 04:02AM
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)